The NEI supports a broad range of basic and clinical research to:

  • Identify the genes that contribute to the pathophysiology of all the forms of glaucoma
  • Establish a consensus definition of OAG (Open Angle Glaucoma) and standardize tools to assess its various phenotypes
  • Develop an end-point measure for OAG
  • Investigate the cellular and molecular mechanisms involved in aqueous humor dynamics including the inflow and outflow pathways and the tissues comprising them
  • Explore neuroprotection as an approach for prolonging RGC function and survival
  • Identify the specific antigenic targets of the aberrant immune response in uveitis and scleritis and determine the role of antigens derived from apoptotic cells in disease
  • Identify genes, transcription factors, and signaling molecules involved in optic nerve degeneration/regeneration
  • Develop experimental approaches comparing models that differ in their optic nerve regenerative capacity, such as fish versus mammal

Program Directors

Bioengineering and Technology
Tom Gover, Ph.D.
tony.gover@nih.gov
301-529-7370

Development and Regeneration
Thomas N. Greenwell, Ph.D.
greenwellt@nei.nih.gov
301-443-5405

Glaucoma
Ellen S. Liberman, Ph.D.
esl@nei.nih.gov
301-435-8174

Last updated: August 3, 2021